Supercritical Fluid Chromatography (SFC) is not only a burgeoning analytical technique, but is developing into a significant tool for purification applications. The inherent qualities of the SFC technique, combined with recent technological improvements, now make it a viable commercial separation method. Although it is still a niche product, purification SFC has a large unrealized potential. […]
Company Announcements Scientific Digital Imaging’s fiscal 2009 revenues for year ended April 30 increased 17.9% to £6.8 million ($11.1 million). Excluding AIM admission expenses and currency gains, operating profit rose 20.7% to £268,000 ($0.2 million) (see IBO 9/15/09). Synoptics, which includes the Syncroscopy, Synbiosis and Syngene brand names, made up 95% of sales. The UK, […]
Company Announcements Fiscal 2009 sales ended March 31 for Takara Biotech’s Genetic Engineering Research segment declined 7.5% to ¥16,733 million ($166.5 million) to make up 88.5% of company revenues. Segment operating income fell 8.4% to ¥3,819 million ($38.0 million). Sales of research reagents and large-scale scientific instruments both declined. The company will focus on developing […]
Company Announcements Endress+Hauser’s 2008 revenues increased 8.8% to €1.211 billion ($1.781 billion). Operating profit increased 7.0% to €156.5 million ($230.1 million). In June, Endress+Hauser Flowtec AG announced a strategic partnership with company Integrated Sensing Systems (ISSYS) for the development of MEMS-based fluidic products. A $3.3 million, 15-company Enterprise Ireland research program to improve the manufacturing […]
Company Announcements Ocean Optics will market and sell Analyze IQ’s Analyze IQ Lab, Analyze IQ Spectra Manager and Analyze IQ Raman Library platforms. In September, Ahura Scientific announced it had reached $100 million in product revenues since its first product shipment in 2005 and that it now serves more than 100 pharmaceutical facilities. Ahura Scientific […]
The Taiwan Food and Drug Administration (TFDA) will be inaugurated on January 1, 2010. Combining the operations of four existing agencies, it will have a staff of 500. The aim of the TFDA is to increase the export of pharmaceutical products and foreign investment by raising regulatory standards and increasing transparency. Source: Economist Intelligence Unit
The South Korean market for clinical lab products was estimated to be $250 million in 2008. Sales of In Vitro Diagnostic (IVD) products accounted for 95% of the market, and is expected to grow 3%–10% over the next three years. Imported products account for 80% of the IVD reagent market and 100% of IVD instrument […]
This month, the Russian government announced an investment of RUB 318 billion ($11 billion) in nanotechnology, building on RUB 94 billion in spending over the last two years. The goal is to create a self-sustaining industry by 2015 to offset the country’s dependence on oil revenue and foreign investment. Currently, Russian nano-enabled products account for […]
In September, China’s State Food and Drug Administration issued a draft of its revised Good Manufacturing Practices for drugs. The public will have until the end of November to make comments. The last GMP standards came into effect in 1999. The new GMP adds an appendix for blood products and expands the appendix addressing sterile […]
AVOS Life Sciences estimates that by 2013, biologics will account for 40% of the 14 major drug companies’ portfolios of branded drugs with more than $500 million in yearly sales, up from 26% last year. For the period, both GlaxoSmithKline (GSK) and Abbott will be among the top three firms in terms of sales and […]
Pay Invoice
Latest Blogs
-
M&A Activity in the Analytical Instrumentation and Lab Tools Market. 2021-2023
September 30, 2024 1:32 pm
-
Survey Results: Life Science Labs and Sustainable Consumables
August 30, 2024 7:43 pm
-
Steady Demand in the Industrial Market for Analytical and Scientific Instrumentation
July 30, 2024 3:07 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
